Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Xi'an Manareco New Materials Co.,Ltd (688550.SS)
CNY51.61
-0.99 (-1.88%)
CN SHH Basic Materials Chemicals - Specialty
Address
High-tech Zone 710077
Xi'an, CN
Xi'an, CN
CEO
Xiaowei Wang
Website
xarlm.com
IPO
2020-09-02
ISIN CNE100005X80
Description
Xi'an Manareco New Materials Co.,Ltd, which commenced operations in 1999, is a company headquartered in Xi'an, China. This enterprise is engaged in the creation and sale of a diverse range of products, including liquid crystal materials, OLED materials, and chemical compounds used in pharmaceutical production.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY51.61
-0.99 (-1.88%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
6M
Beta
0.73
Float Shares
79.77M
Free Float %
45.9%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
51.61
DCF (Levered)
4.16
-91.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
13.83
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
6 / 10
Developing
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%+15.0% ★ Q1'26: +10.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+24.1% ★ Q1'26: -3.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+12.8% Q1'26: -6.5% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+21.3% ★ Q1'26: +15.6% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+14.5% ★ Q1'26: +9.5% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.5% ★ Q1'26: -0.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.00× ★ Q1'26: 0.02× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
1.05B
est: 1.05B (0.0%)
|
1.53B
est: 1.41B (+8.0%)
|
1.48B
est: 1.68B (-11.8%)
|
1.21B
est: 1.29B (-6.0%)
|
1.46B
est: 1.33B (+9.5%)
|
1.68B
est: 1.66B (+1.0%)
|
2.01B
1.83B – 2.14B
+21.2% YoY
|
2.37B
2.26B – 2.44B
+17.6% YoY
|
| EBITDA |
289.75M
est: 246.04M (+17.8%)
|
353.13M
est: 330.86M (+6.7%)
|
378.41M
est: 393.19M (-3.8%)
|
293.59M
est: 301.24M (-2.5%)
|
449.74M
est: 312.12M (+44.1%)
|
514.71M
est: 388.92M (+32.3%)
|
471.41M
428.10M – 500.83M
+21.2% YoY
|
554.35M
529.13M – 571.48M
+17.6% YoY
|
| EBIT |
215.70M
est: 157.39M (+37.0%)
|
272.53M
est: 211.65M (+28.8%)
|
274.37M
est: 251.53M (+9.1%)
|
148.54M
est: 192.70M (-22.9%)
|
291.60M
est: 199.66M (+46.0%)
|
356.57M
est: 248.79M (+43.3%)
|
301.56M
273.85M – 320.38M
+21.2% YoY
|
354.62M
338.48M – 365.57M
+17.6% YoY
|
| Net Income |
175.41M
est: 169.99M (+3.2%)
|
239.78M
est: 231.65M (+3.5%)
|
246.54M
est: 266.13M (-7.4%)
|
134.18M
est: 171.22M (-21.6%)
|
251.72M
est: 270.25M (-6.9%)
|
310.83M
est: 310.83M (+0.0%)
|
399.71M
375.31M – 414.93M
+28.6% YoY
|
471.81M
443.55M – 490.37M
+18.0% YoY
|
| SGA |
148.13M
est: 154.17M (-3.9%)
|
192.76M
est: 207.32M (-7.0%)
|
208.99M
est: 246.37M (-15.2%)
|
199.33M
est: 188.76M (+5.6%)
|
234.10M
est: 195.57M (+19.7%)
|
132.48M
est: 243.69M (-45.6%)
|
295.38M
268.24M – 313.82M
+21.2% YoY
|
347.35M
331.55M – 358.08M
+17.6% YoY
|
| EPS |
1.18
est: 0.98 (+20.5%)
|
1.34
est: 1.33 (+0.4%)
|
1.38
est: 1.53 (-10.0%)
|
0.75
est: 0.98 (-23.6%)
|
1.45
est: 1.58 (-8.2%)
|
1.80
est: 1.90 (-5.0%)
|
2.31
2.17 – 2.40
+21.9% YoY
|
2.73
2.57 – 2.84
+18.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
233.29M
OE per share TTM
1.36
Owner's Yield
3.26%
Maintenance CapEx ratio
3.43%
Maint CapEx / Avg PPE
72.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 4 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 314.4K | 0.39% |
| 2 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 407.5K | 0.28% |
| 3 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 35.4K | 0.46% |
| 4 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 105.2K | 0.29% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
214.4K
Shares Outstanding
173.84M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hanjiang He | Pharmaceutical R&D Manager | — | male |
| Jiangbo Yuan | Deputy General Manager | — | male |
| Qiang Guo | LCD R&D Manager | — | male |
| Quan Zhou | Deputy General Manager | — | male |
| Tong Zhao | Quality Inspection Director | — | female |
| Xiaobo Qian | Deputy General Manager | — | male |
| Xiaowei Wang | GM, Chief Engineer & Director | — | male |
| Yinbin Wang | Deputy GM, Chief Financial Officer & Board Secretary | — | male |
| Zhan Hu | Deputy General Manager | — | male |
| Zongxue Hu | Deputy General Manager | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 688550.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
